Glaxo Forks Over $70M in Drug-Pricing Fraud
GlaxoSmithKline PLC has agreed to shell out an estimated $70 million to put to rest claims that the pharmaceutical giant artificially inflated the prices of various drugs, including cancer medications....To view the full article, register now.
Already a subscriber? Click here to view full article